Lynnetta Watts
3Patents
2h-index
8Co-inventors
30Inventor score
Filing activity: Sep 21, 2004 → Jun 24, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8258105B2 | Antisense oligonucleotides optimized for kidney targeting | Chemistry; Metallurgy | 9 | Expired |
| US7919476B2 | Modulation of glucagon receptor expression | Chemistry; Metallurgy | 2 | Active |
| US8084436B2 | Modulation of SGLT2 expression | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.